Expansion of Evonik’s MetAMINO® production in Singapore is completed

• MetAMINO^® production in Singapore back operating at full capacity
• Collaboration with Linde enables the use of green hydrogen
• Product carbon footprint of Evonik’s DL-methionine from Singapore further reduced by six percent

The expansion of Evonik’s MetAMINO^® (DL- methionine) production facilities in Singapore site has been completed. The MetAMINO^® production on Jurong Island is again running at full capacity, after shutdowns in Q4/2023 and Q2/2024. The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year. The expansion was accomplished ahead of schedule.

Through process intensification, Evonik has optimized its methionine production plants, generating a surplus of steam that is used to produce on-site electricity.

Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a nine-megawatt alkaline electrolyzer plant, which is the largest of its kind ever installed in Singapore. The unit enables Evonik's efforts to use green hydrogen required for the MetAMINO^® production and reflects the company's commitment to sustainability and reducing its environmental impact.

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of MetAMINO^® at this site (Scope 1+2+3) by six percent compared to before the expansion.

In 2023, Evonik set its own science-based targets that have been approved by the Science Based Targets Initiative (SBTi) as consistent with a well-below 2°C (WB2C) pathway. “We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway, and reach net-zero emissions by 2050”, says Gaetano Blanda, head of the Animal Nutrition business line.

MetAMINO^® is used in livestock production to feed animals healthily, efficiently, and sustainably. With its science-based approach, the Animal Nutrition business line of Evonik develops products, services and system solutions that help supply a growing world population with healthy, high-quality and affordable animal protein. Animal Nutrition is part of Evonik's Nutrition & Care division and contributes significantly to the profitable growth of Nutrition & Care through its self-financing power.